On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos Capital, Ron Seubert, featuring lead investors Arboretum Ventures.

About the company: RareCyte is located at United States, North America.
“Precision Biology solutions focused on multiplexed analysis of cells and tissue with applications in both research and clinical diagnostics.”

Company website: http://www.rarecyte.com